ACCESS Newswire
13 Aug 2020, 17:35 GMT+10
Ophthalmic drug manufacturers are leveraging the growing rate of FDA approvals for novel drug offerings to introduce new products and revenue streams in the market.
ROCKVILLE, MD / ACCESSWIRE / August 13, 2020 / The global ophthalmic drugs market is anticipated to show a moderate growth rate of 4.2% CAGR between the forecasting years from 2020 to 2025. The coronavirus pandemic is likely to have a detrimental impact on the ophthalmic drugs market. Government guidelines postponing elective ophthalmic procedures and consultations are hurting demand for ophthalmic drugs. In addition, fears over covid-19 transmission through ocular secretions is also hampering short term prospects.
'Growing use of novel therapeutics in the field of ophthalmology, coupled with higher numbers of eye ailments, are major drivers for the ophthalmic drugs industry. Further, faster approvals for new offerings and growing patient awareness treatment options will contribute to market developments,' says the FACT.MR analyst.
Request a sample of the report to gain more market insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4799
Ophthalmic Drugs Market- Key Takeaways
Ophthalmic Drugs Market- Driving Factors
Ophthalmic Drugs Market- Major Restraints
COVID-19 Impact on Ophthalmic Drugs Market
The coronavirus pandemic is having a negative impact on the ophthalmic drugs market owing to suspension of non-critical operations in the ophthalmic sector of the healthcare industry. In addition, the industry is facing challenges in supply chains, owing to disruptions of raw material production. Concerns over ocular transmission of the virus also hurts short term prospects. However, the market is likely to witness strong recovery post pandemic, driven by high numbers of eye disorder incidences and resurgence of ophthalmic treatment services.
Explore the global Ophthalmic Drugs market with 90 figures, 55 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4799/opthalmic-drugs-market
Competitive Landscape
Santen Pharmaceutical Co., Novartis AG, Allergan, and Regeneron Pharmaceuticals Inc. are some of the leading ophthalmic drug manufacturers in the global market.
Ophthalmic drugs market players displaying greater bias towards the development and launch of new drug formulations to widen their portfolio of solutions for ocular ailments.
For instance, Eyevance has announced the FDA approval of Zerviate, a cetirizine ophthalmic solution aimed towards treating allergic conjunctivitis. Horizon Therapeutics has announced the approval of Teprotumumab for thyroid eye disease in adults. Further, Allergan has also announced the approval of Artemis, a new biodegradable glaucoma implant drug.
About the Report
This study offers readers a comprehensive market forecast of the ophthalmic drugs market. Global, regional and country-level analysis of the top industry trends impacting the ophthalmic drugs market is covered in this FACT.MR study. The report offers insights on the ophthalmic drugs market on the basis of disease indication (dry eye, glaucoma, infection, retinal disorders, allergy, uveitis, and others), therapeutic class (anti-inflammatory drugs, anti-infective drugs, anti-glaucoma drugs, anti-allergy drugs, anti-VEGF drugs, and others) product type (prescription drugs and OTC drugs) and distribution channel (hospital pharmacies, online pharmacies, and independent pharmacies), across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Explore FACT.MR's Comprehensive Coverage of Healthcare Landscape
OTC Vitamins & Dietary Supplements Market- Get the latest insights on the global OTC vitamins & dietary supplements market through FACT.MR's report covering analysis for projection period (2017-2022).
OTC Cough, Cold & Allergy Medicine Market- FACT.MR's study on the global OTC cough, cold & allergy medicine market covers trends, tech innovations, players, and strategies for 2017-2022.
OTC Analgesics Market- Obtain analysis on the global OTC analgesics market through FACT.MR's latest report covering competitive analysis, key regions, along with segmental analysis for 2017-2022.
About Fact.MR
Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FACT.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.
Contact:
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: [email protected]
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1567/global-opthalmic-drugs-market
SOURCE: Fact.MR
Get a daily dose of Baltimore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Baltimore Star.
More InformationSAN FRANCISCO, California: Grammarly is doubling down on AI-powered productivity tools with the acquisition of Superhuman, a sleek...
NEW YORK, New York -U.S. stock markets closed with broad gains on Thursday, led by strong performances in U.S. tech stocks, while European...
LONDON/STOCKHOLM: The Persson family is ramping up its investment in the H&M fashion empire, fueling renewed speculation about a potential...
PARIS, France: L'Oréal is making a fresh play in the booming premium haircare segment with a new acquisition. The French beauty conglomerate...
MENLO PARK, California: Robinhood is giving European investors a new way to tap into America's most prominent tech names — without...
NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...
SAN FRANCISCO, California: Grammarly is doubling down on AI-powered productivity tools with the acquisition of Superhuman, a sleek...
NEW YORK, New York -U.S. stock markets closed with broad gains on Thursday, led by strong performances in U.S. tech stocks, while European...
LONDON/STOCKHOLM: The Persson family is ramping up its investment in the H&M fashion empire, fueling renewed speculation about a potential...
PARIS, France: L'Oréal is making a fresh play in the booming premium haircare segment with a new acquisition. The French beauty conglomerate...
MENLO PARK, California: Robinhood is giving European investors a new way to tap into America's most prominent tech names — without...
NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...